Deciphering the potential mechanism of Siwu decoction for treating cancer-related anemia based on network pharmacology and molecular docking technology

Background:Siwu decoction(SWD)is a traditional Chinese herbal decoction commonly used for treating various symptoms of blood deficiency and blood stasis,including cancer-related anemia(CRA).However,due to its complex composition,the key active ingredients and underlying mechanisms of its therapeutic effects often remain unknown.This research aims to use network pharmacology and molecular docking technology to systematically elucidate the potential mechanisms underlying the efficacy of SWD in treating cancer-related anemia.Methods:The key constituents of SWD were procured from the TCMSP database.Leveraging the Swiss ADME and Swiss Target Prediction databases,potential targets were recognized.Disease-related targets were assembled via the GeneCards and DrugBank databases.Constructing the PPI network involved the utilization of the STRING database,followed by visualization through Cytoscape 3.9.1 software.Subsequently,GO and KEGG enrichment analysis was conducted utilizing the DAVID database,with visual analysis performed on the macrobiotic platform.For molecular docking,the Autodock software was employed,and the molecular docking outcomes were visualized using the PyMOL software.Results:In this investigation,a comprehensive revelation of 18 primary active compounds and 511 associated targets linked to CRA was accomplished.The outcomes of protein-protein interaction(PPI)analysis unequivocally identified AKT1,EGFR,SRC,VEGFA,HRAS,MAPK3,and STAT3 as pivotal proteins within the SWD’s framework for effective CRA intervention.Notably,signaling pathways such as the HIF-1,JAK-STAT,TNF-α,and PI3K-Akt pathways,intricately involved in hematopoietic stem cell proliferation,differentiation,and inflammatory response,emerged as closely intertwined with the therapeutic application of SWD for CRA treatment.The congruence between these potential targets and SWD’s primary therapeutic constituents for CRA treatment was substantiated by the outcomes of molecular docking analysis.Conclusion:This work provided a reference for further fundamental research by outlining the primary active ingredients and putative molecular mechanisms of SWD in the treatment of CRA.

Screening of active ingredients of Taohong Siwu Decoction on platelet membrane receptor

OBJECTIVE To screen the active ingredients preventing platelet aggregations from Taohong Siwu Decoction. METHODS Fresh blood from healthy adult volunteer was collected with vacuum tube for preparation of platelet suspension. Platelet suspension was incubated with Taohong Siwu Decoction for one hour at 37℃,then centrifuged. The precipitate was washed and desorbed with buffer solutions.The differences of chemical constituents between incubated and unincubated were identified with high performance liquid chromatography-diode array detector. RESULTS According to the chromatograph at 254 nm,at least three kinds of different components were detected in Taohong siwu decoction before and after incubated with platelet. CONCLUSION Platelet suspension can be used for screening active ingredients on platelet membrane receptor from the traditional Chinese medicine.

Meta-analysis of efficacy of Taohong Siwu Decoction in the treatment of diabetic peripheral neuropathy

Objective:To evaluate the clinical efficacy of combined/single use of Taohong Siwu decoction in the treatment for diabetic peripheral neuropathy(DPN)by meta-analysis.Methods:Database were searched electronically from the time databases established to November 2020 to collect randomized controlled trials of Taohong Siwu decoction combined with non-specific therapy for DPN in Chinese or English.The trial was assessed by 2 researchers independently,RevMan 5.3 software was used for meta-analysis.Results:A total of 13 studies included 970 patients.Meta-analysis showed that the combined/single use of Taohong Siwu decoction can further improve median sensory nerve velocity〔MD=4.86,95%CI(2.70,7.03),P<0.00001〕,and the curative effect〔OR=4.35,95%CI(3.1,6.06),P<0.00001〕,increase the velocity of the motor nerve〔MD=6.84,95%CI(6.14,7.55),P<0.00001〕,and the velocity of the sensory nerve〔MD=7.46,95%CI(5.84,9.08),P<0.00001〕,decrease TCM syndrome score〔MD=-5.61,95%CI(-6.63,-4.60),P<0.00001〕,and fasting blood-glucose〔MD=-0.24,95%CI(-0.37,-0.11),P<0.00001〕.The GRADE showed B level of evidence.Conclusion:Combined/single use of Taohong Siwu decoction in the treatment for DPN is effective.The safety is not clear,and more high-quality clinical studies are expected to be included to provide evidence support.

Research progress of Taohong Siwu Decoction and its modified prescription in the treatment of diabetic peripheral neuropathy

Western medicine mainly focuses on the conventional basic treatment of Diabetic peripheral neuropathy(DPN),such as blood glucose control,anti-oxidative stress,and nerve nutrition,but the efficacy and safety of the drugs cannot be guaranteed.As an important prescription for promoting blood circulation,removing blood stasis and nourishing blood,Taohong Siwu Decoction can not only promote cell proliferation and repair,reduce inflammatory factors in the blood,reduce the whole blood viscosity and plasma viscosity,and has a good anticoagulation effect.Moreover,Taohong Siwu Decoction and its added or subtracted prescription,foot bath and combined acupuncture have the effect of regulating blood sugar,improving nerve conduction velocity and relieving clinical symptoms,without obvious adverse reactions.This article reviews Taohong Siwu Decoction and its addition and subtraction in the treatment of diabetic peripheral neuropathy.

Effects of Taohong Siwu Decoction on coagulation function and PI3K/AKT/mTOR pathway after femoral artery anastomosis in rabbits

Objective:To observe the effect of Taohong Siyu Decoction on the coagulation function and the signaling pathway of PI3K(phosphatidylinositol 3-kinase)/AKT(protein kinase B)/mTOR(mammalian target of rapamycin)after femoral artery anastomosis in rabbits.Methods:30 New Zealand white rabbits were divided into blank control group,model control group,papavine hydrochloride injection group and low,medium and high dose groups of Taohong Siwu decoction by random number table method,with 5 rabbits in each group.The rabbits in the model control group,papavine hydrochloride injection group and low,medium and high dose groups of Taohong Siwu decoction were treated with the femoral artery simple intermittent end-to-end suture model.After the successful modeling,the low,medium and high dose groups of Taohong Siwu decoction were given the Taohong Siwu decoction,while the model control group,the blank control group and papavine hydrochloride injection group were given the same amount of normal saline.APTT(activated partial thromboplastin time),FIB(fibrinogen)and PI3K/AKT/mTOR concentrations were measured in aural venous blood samples from six groups of rabbits 30min before operation and 1d,2D,3D and 7d after operation,respectively.Statistical analysis was conducted on the data of the six groups.Results:Compared with blank control group,APTT of model control group was significantly shortened 1d to 7d after operation(P<0.05),FIB values were significantly increased from 1d to 7d after operation(P<0.05);Compared with model control group,APTT in Taohong Siwu decoction low-dose,medium-dose and high-dose groups were significantly prolonged 1d to 7d after operation(P<0.05),FIB value of Taohong Siwu decoction medium and high dose groups decreased significantly from 1d to 7d after operation(P<0.05),the FIB value of Taohong Siwu decoction low-dose group was significantly decreased from 2d to 7d after surgery(P<0.05);Compared with papaverine hydrochloride injection group,APTT in Taohong Siwu decoction medium dose group was significantly prolonged 2d to 7d after surgery(P<0.05),APTT of Taohong Siwu decoction high-dose group was significantly prolonged on 1d to 7d after operation(P<0.05).FIB in Taohong Siwu decoction medium and high dose groups decreased significantly 1d to 7d after operation(P<0.05);Compared with the blank control group,the expression concentrations of PI3K,Akt and mTOR in serum of the model control group were significantly increased from 1d to 7d after surgery(P<0.05);Compared with the model control group,the expression levels of PI3K,Akt and mTOR in serum were significantly increased in the low dose group of Taohong Siwu decoction and Papaverine Hydrochloride Injection group on postoperative 7 days(P<0.05),Taohong Siwu decoction high-dose group was significantly increased from 1d to 7d after surgery(P<0.05),the expression concentrations of PI3K and Akt in Taohong Siwu decoction medium dose group were significantly increased from 2d to 7d after operation(P<0.05),mTOR expression levels were significantly increased from 3d to 7d after operation(P<0.05);Compared with papaverine hydrochloride injection group,the expression concentrations of PI3K,Akt and mTOR in serum of Taohong Siwu decoction medium dose group were significantly increased from 3d to 7d after operation(P<0.05),the expression concentrations of PI3K and mTOR in Taohong Siwu decoction high-dose group were significantly increased from 1d to 7d after operation(P<0.05),and the expression concentration of Akt increased significantly from 3d to 7d after operation(P<0.05).Conclusion:The Taohong Siwu decoction can improve the coagulation function of rabbit femoral artery anastomosis,prevent thrombosis,activate PI3K/Akt/mTOR signaling pathway,promote angiogenesis,and improve tissue ischemia after artery anastomosis.

The famous Chinese medicine doctor Xue Jing-Dong Taohong Siwu Decoction cured 1 case of primary liver cancer stage Ⅲa

Primary liver cancer is the most common malignant tumor of the liver.Surgery,intervention,radiotherapy,and chemotherapy are the main treatment methods in the early stage,and the basic principles of post-treatment are palliative treatment and symptomatic treatment.Xue Jing-Dong,a famous Chinese doctor,started from the etiology and pathogenesis of liver cancer,used the methods of promoting blood circulation to remove blood stasis,nourishing blood and replenishing liver,and applied Taohong Siwu Decoction based on long-term clinical experience to cure 1 case of primary liver cancer stage Ⅲa in two years.The patient’s survival period can be prolonged and the quality of life can be improved.The author begins with the diagnosis of stage Ⅲa liver cancer,western medicine treatment methods,and previous treatment experience of traditional Chinese medicine,and briefly describes the diagnosis and treatment of this patient.

四物汤的药理作用研究进展

四物汤是补血调血的基础方,具有补血不滞血、行血不伤血的特点,常用于治疗临床多种疾病,具有较高的临床价值。笔者通过综述相关研究文献发现,四物汤具有补充血容量、活血抗凝、雌激素样作用、子宫双向调节、改善卵巢功能、降血脂、提高学习记忆能力、抗氧化损伤、抗炎抗菌、提高免疫功能、抗衰老、保肝和抗辐射、药物损伤及抗突变等药理作用,主要作用在血液系统、女性生殖系统与心脑血管系统,主要通过磷脂酰肌醇-3-激酶/蛋白激酶B(PI3K/Akt)信号通路、表皮生长因子受体/磷脂酰肌醇3-激酶(EGFR/PI3K)信号通路、肝激酶B1/腺苷酸活化蛋白激酶(LKB1/AMPK)信号通路等发挥治疗作用。

参芪桃花四物汤合复遂汤联合针刺对气虚血瘀证缺血性脑梗死恢复期痉挛性瘫痪患者的临床疗效

目的探讨参芪桃花四物汤合复遂汤联合针刺对气虚血瘀证缺血性脑梗死恢复期痉挛性瘫痪患者的临床疗效。方法92例患者随机分为对照组和观察组,每组46例,2组采用常规治疗,同时对照组给予针刺,观察组在对照组基础上加用参芪桃花四物汤合复遂汤,疗程4周。检测临床疗效、中医证候评分、血清学指标(Glu、GABA、Glu/GABA、Gly、HCY、ASP)、神经功能指标(BDNF、NGF、NT-3)、NIHSS评分、FMA评分、MAS评分、Barthel评分、表面肌电信号(Hmax、Mmax、Hmax/Mmax)、不良反应发生率变化。结果观察组总有效率高于对照组(P<0.05)。治疗后,2组GABA、Gly、神经功能指标、FMA评分、Barthel评分升高(P<0.05),中医证候评分、Glu、Glu/GABA、HCY、ASP、NIHSS评分、MAS评分、表面肌电信号降低(P<0.05),以观察组更明显(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论参芪桃花四物汤合复遂汤联合针刺可安全有效地改善气虚血瘀证缺血性脑梗死恢复期痉挛性瘫痪患者神经功能、运动功能、生活质量,降低中医证候评分、痉挛程度。

柴胡四物汤对围绝经期综合征模型大鼠血清E_(2)水平、子宫形态及ERα表达的影响

目的:通过观察柴胡四物汤对围绝经期综合征模型大鼠血清E_(2)水平、子宫形态及子宫、下丘脑ERα表达的影响,初步探讨柴胡四物汤治疗围绝经期综合征的作用机制。方法:将75只雌性SD大鼠随机分为假手术组、模型组、西药组、柴胡四物汤高、中、低剂量组,采用双侧卵巢切除法造模,选取符合条件的60只大鼠纳入实验,每组10只。从术后第14天开始,连续给药28 d。给药结束后,观察各组大鼠子宫指数及形态学的改变;采用ELISA法检测血清E_(2)水平;采用RT-PCR法及Western Blot法检测子宫、下丘脑ERα的表达水平。结果:与假手术组比较,模型组血清E_(2)水平明显下降(P<0.01),子宫湿重、子宫指数显著下降(P<0.01),子宫体积明显缩小,宫腔变窄,腺体数量较少,内膜及肌层萎缩,子宫ERαmRNA及蛋白的表达水平明显下降(P<0.01),下丘脑ERαmRNA及蛋白的表达水平显著升高(P<0.01)。与模型组比较,西药组、柴胡四物汤高、中剂量组血清E_(2)水平明显升高(P<0.01),西药组、柴胡四物汤高、中、低剂量组的子宫指数明显上升(P<0.01),子宫腺体数量增加,内膜及肌层的萎缩程度有所缓解,西药组、柴胡四物汤高、中剂量组子宫ERαmRNA表达水平增加(P<0.01),西药组、柴胡四物汤高剂量组子宫ERα蛋白表达水平增加(P<0.01),西药组、柴胡四物汤高、中、低剂量组下丘脑ERαmRNA及蛋白的表达水平降低(P<0.01)。结论:柴胡四物汤可改善围绝经期的各类症状,其作用机制可能与升高围绝经期综合征模型大鼠血清E_(2)水平,改善子宫指数及萎缩程度,提高子宫ERα的表达并同时下调下丘脑ERα的表达有关。

基于转录组测序探讨加味桃红四物汤缓解大鼠心肌缺血再灌注损伤的作用机制

目的 基于转录组测序研究加味桃红四物汤对大鼠心肌缺血再灌注损伤的影响及作用机制。方法 将15只SPF级大鼠随机分为假手术组、模型组和加味桃红四物汤组,每组5只,加味桃红四物汤组予加味桃红四物汤预灌胃5 d,假手术组和模型组灌胃等体积蒸馏水,建立心肌缺血再灌注损伤大鼠模型。心脏超声检测大鼠心功能,试剂盒检测血清氧化应激和炎症因子含量,TUNEL染色检测心肌细胞凋亡,取心肌组织进行转录组测序,对差异基因进行韦恩图及热图分析,对共同差异基因进行GO功能分析和KEGG通路富集分析。RT-qPCR验证差异基因PTX3和EGR2表达。结果 与假手术组比较,模型组大鼠射血分数(EF)和短轴缩短率(FS)明显降低(P<0.01),心肌组织细胞凋亡率及血清乳酸脱氢酶(LDH)、肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1β、IL-6含量明显升高(P<0.01),SOD活性和IL-10含量明显降低(P<0.01);与模型组比较,加味桃红四物汤组大鼠EF和FS明显升高(P<0.05),心肌组织细胞凋亡率及血清肌酸激酶同工酶、LDH、TNF-α、IL-1β、IL-6含量明显降低(P<0.01),SOD活性和IL-10含量明显升高(P<0.01)。转录组测序得到假手术组与模型组差异基因4 227个(2 259个上调、1 968个下调),假手术组与加味桃红四物汤组差异基因1 933个(1301个上调、632个下调),模型组与加味桃红四物汤组差异基因94个(46个上调、48个下调),3组共同差异基因35个,差异基因主要富集到流体剪切力和动脉粥样硬化、泛素介导的蛋白质降解、C型凝集素受体信号通路、鞘脂类信号通路、细胞周期、趋化因子信号通路、脂质和动脉粥样硬化等信号通路。RT-qPCR验证结果显示,模型组心肌组织PTX3和EGR2基因表达较假手术组明显升高(P<0.01),加味桃红四物汤组PTX3和EGR2基因表达较模型组明显降低(P<0.01)。结论 加味桃红四物汤对心肌缺血再灌注损伤具有缓解作用,表现为改善模型大鼠心功能、减少细胞凋亡和炎症因子释放及减轻氧化应激水平,其机制可能与调控PTX3和EGR2基因表达有关。

桃红四物汤联合射频消融治疗下肢静脉曲张合并血栓性静脉炎临床研究

[目的]探究桃红四物汤联合射频消融治疗下肢静脉曲张合并血栓性静脉炎患者的临床疗效。[方法]选择2020年1月至2022年1月于医院治疗的下肢静脉曲张合并血栓性静脉炎患者100例,采用随机数字表法分为射频消融组与桃红四物汤联合组各50例,射频消融组给予患者射频消融治疗,桃红四物汤联合组给予患者桃红四物汤联合射频消融治疗,治疗前、后检测两组患者可溶性血管细胞黏附分子-1(sVCAM-1)、肿瘤坏死因子-α(TNF-α)、白介素-1β(IL-1β)、D-二聚体、一氧化氮(NO)、血栓素B2(TXB2)、内皮素-1(ET-1)、血管性血友病因子(vWF)、6-酮-前列腺素F1α(6-Keto-PGF1α)、纤维蛋白原、血细胞比容、血浆黏度水平,给予患者皮肤温度、肿胀程度、皮肤颜色、疼痛程度评价,比较两组临床疗效。[结果]治疗后,桃红四物汤联合组TNF-α、sVCAM-1、IL-1β、D-二聚体、TXB2、6-Keto-PGF1α、ET-1、vWF、纤维蛋白原、血细胞比容、血浆黏度水平及皮肤温度、肿胀程度、皮肤颜色、疼痛程度评分低于射频消融组(P<0.05);桃红四物汤联合组NO水平、总有效率较射频消融组高(P<0.05)。[结论]给予下肢静脉曲张合并血栓性静脉炎患者桃红四物汤联合射频消融治疗,可抑制炎症,减少血管内皮损伤,改善血液流变学及微循环,缓解患者临床症状,提升患者临床疗效。

桃红四物汤加味联合穴位贴敷治疗带状疱疹后遗神经痛患者的临床疗效及作用机制

目的探讨桃红四物汤加味联合穴位贴敷治疗带状疱疹后遗神经痛(Postherpetic nerualgia,PHN)患者的临床疗效及作用机制。方法选取2021年2月—2023年2月期间成都中医药大学附属医院疼痛科收治的93例PHN患者,按入院顺序分为对照组46例和观察组47例。其中对照组脱落3例,观察组脱落2例,最终88例完成试验,每组各44例。对照组采用常规西药治疗,观察组在对照组基础上加用桃红四物汤加味和穴位贴敷治疗。治疗4周后,观察比较两组患者治疗前后疼痛情况[视觉模拟评分(Visual analogue scales,VAS)、疼痛持续时间积分、疼痛间隔时间积分]、炎症因子[环氧化酶-2(Cyclooxygenase-2,COX-2)、肿瘤坏死因子-α(Tumor necrosis factor,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)、白细胞介素-1β(Interleukin-1β,IL-1β)、白细胞介素-10(Interleukin-10,IL-10)]、疼痛介质[P物质(Substance P,SP)、神经肽Y(Neuropeptide Y,NPY)、β-内啡肽(β-endorphin,β-EP)]、T淋巴细胞亚群(CD3^(+)、CD4^(+)、CD8^(+)、CD4^(+)/CD8^(+))变化情况,评估临床疗效及安全性。结果治疗后两组患者VAS、疼痛持续时间积分、疼痛间隔时间积分均较治疗前降低,差异有统计学意义(P<0.05);且观察组各疼痛积分明显低于对照组,差异有统计学意义(P<0.05)。治疗后两组患者COX-2、TNF-α、IL-6、IL-1β水平均较治疗前降低,IL-10水平均较治疗前升高,差异有统计学意义(P<0.05);且观察组COX-2、TNF-α、IL-6、IL-1β水平均明显低于对照组,IL-10水平明显高于对照组,差异有统计学意义(P<0.05)。治疗后两组患者血清SP、NPY水平均较治疗前降低,β-EP水平均较治疗前升高,差异有统计学意义(P<0.05);且观察组血清SP、NPY水平均明显低于对照组,β-EP水平明显高于对照组,差异有统计学意义(P<0.05)。治疗后两组患者CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)均较治疗前升高,CD8^(+)均较治疗前降低,差异有统计学意义(P<0.05);且观察组CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)均明显高于对照组,CD8^(+)明显低于对照组,差异有统计学意义(P<0.05)。治疗后观察组临床总有效率90.91%(40/44)明显高于对照组79.55%(35/44),差异有统计学意义(P<0.05)。治疗期间,两组患者不良反应率比较,差异无统计学意义(P>0.05)。结论桃红四物汤加味联合穴位贴敷治疗PHN能减轻疼痛症状,临床疗效确切,其机制推测与降低炎性因子表达,抑制疼痛介质释放,调节免疫功能相关。

基于网络药理学方法和分子对接技术探讨芍药甘草汤合桃红四物汤治疗糖尿病周围神经病变的作用机制

目的:运用网络药理学方法及分子对接技术探讨芍药甘草汤合桃红四物汤治疗糖尿病周围神经病变(DPN)的作用机制。方法:利用中药系统药理学数据库与分析平台(TCMSP)数据库筛选芍药甘草汤合桃红四物汤的活性成分及相关靶点信息;从DrugBank、PharmGKB、GeneCards、OMIM和TTD数据库中获取DPN的靶点基因。运用Cytoscape软件、STRING数据库构建芍药甘草汤合桃红四物汤活性成分-DPN共同靶点基因关系网络及共同靶点基因的蛋白质相互作用(PPI)网络。利用R语言软件进行基因本体论(GO)功能富集分析和京都基因与基因组百科全书(KEGG)通路富集分析。采用AutoDock Vina软件进行分子对接。结果:共获得161个芍药甘草汤合桃红四物汤活性成分,184个芍药甘草汤合桃红四物汤活性成分-DPN共同靶点基因。核心活性成分为槲皮素、木犀草素、山奈酚、柚皮素、7-甲氧基-2-甲基异黄酮,核心靶点基因为信号传导及转录激活蛋白3(STAT3)、丝裂原活化蛋白激酶3(MAPK3)、热休克蛋白90AA1(HSP90AA1)、丝裂原活化蛋白激酶1(MAPK1)、转录因子p65(RELA)。GO功能富集分析得到2940条GO条目,KEGG通路富集分析得到182条信号通路。分子对接结果显示,木犀草素与HSP90AA1的结合活性最好。结论:芍药甘草汤合桃红四物汤具有多成分、多靶点、多通路的效应特点,其作用机制可能是槲皮素、木犀草素、山奈酚、柚皮素、7-甲氧基-2-甲基异黄酮等活性成分作用于STAT3、MAPK3、HSP90AA1、MAPK1、RELA等靶点基因,调控磷脂酰肌醇3-激酶/蛋白激酶B(PI3K-Akt)、晚期糖基化终末产物-晚期糖基化终末产物受体(AGE-RAGE)、白细胞介素-17(IL-17)、肿瘤坏死因子(TNF)、缺氧诱导因子1(HIF-1)等多条信号通路,通过抗氧化应激、抑制炎症反应、保护神经细胞、改善胰岛素抵抗发挥治疗DPN的作用。

涤痰汤合桃红四物汤加减治疗痰瘀阻络型脑梗死恢复早期临床观察

目的:观察涤痰汤合桃红四物汤加减治疗痰瘀阻络型脑梗死恢复早期的临床疗效。方法:选取符合纳入标准的痰瘀阻络型脑梗死恢复早期患者96例,采用随机数字表法分为两组各48例。对照组予常规对症治疗及个体化康复综合训练,治疗组在对照组基础上予涤痰汤合桃红四物汤加减治疗。比较两组神经功能缺损程度、中医证候积分、神经损伤因子水平、脑血流动力学指标水平。结果:治疗后,两组卒中量表(NIHSS)评分、中医证候积分、各项神经损伤因子水平、各项脑血流动力学指标水平均较治疗前改善(P﹤0.05),且治疗组改善幅度均优于对照组(P﹤0.05)。结论:涤痰汤合桃红四物汤加减对痰瘀阻络型脑梗死恢复早期脑神经的保护作用较好,可有效改善脑血流动力学。

加味桃红四物汤联合利伐沙班在髋关节置换术后的应用

目的探讨加味桃红四物汤联合利伐沙班在髋关节置换术后应用的效果,旨在评估其对术后血栓预防、炎症因子水平及并发症的影响。方法本研究为随机对照试验,前瞻性选取2019年11月至2023年11月在宝鸡市中医医院行髋关节置换手术的120例患者,采用随机数字表法将患者分为观察组(60例)和对照组(60例)。观察组男30例,女30例;年龄(65.25±10.33)岁;病程(4.72±1.15)年。对照组男28例,女32例;年龄(63.96±10.87)岁;病程(4.68±1.13)年。对照组采用利伐沙班治疗方案,观察组采用加味桃红四物汤与利伐沙班的联合治疗方案。比较两组在治疗前及治疗14 d后的凝血功能指标[血浆凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)及D-二聚体(D-D)]、血流变学指标(全血粘度、血浆粘度、红细胞比容、红细胞刚性指数及红细胞变形指数)、促炎性细胞因子指标[C反应蛋白(CRP)]、并发症及深静脉血栓(DVT)方面的差异。采用独立样本t检验、配对样本t检验和χ^(2)检验。结果治疗前,两组各项指标比较,差异均无统计学意义(均P>0.05)。治疗14 d后,观察组PT[(15.79±2.33)s]、TT[(19.05±3.12)s]和APTT[(30.21±4.07)s]均长于对照组[(14.01±2.67)s、(15.52±2.79)s、(27.33±3.49)s](均P<0.05);观察组FIB[(3.52±1.08)g/L]和D-D水平[(0.22±0.04)mg/L]均低于对照组[(4.09±1.06)g/L、(0.33±0.06)mg/L](均P<0.05)。治疗14 d后,观察组全血粘度[(4.07±1.28)mPa·S]、血浆粘度[(1.48±0.43)mPa·S]、红细胞比容[(37.56±2.79)%]、红细胞刚性指数(5.47±0.77)均低于对照组[(4.65±0.27)mPa·S、(2.02±0.39)mPa·S、(42.06±2.17)%、(6.23±0.84)](均P<0.05);观察组红细胞变形指数(0.84±0.03)高于对照组(0.74±0.07)(P<0.05)。治疗14 d后,观察组CRP水平[(4.25±1.09)mg/L]低于对照组[(7.97±2.14)mg/L](P<0.05)。治疗后14 d内,观察组并发症总发生率[13.33%(8/60)]和DVT阳性率[6.67%(4/60)]均低于对照组[25.00%(15/60)、20.00%(12/60)](均P<0.05)。结论加味桃红四物汤与利伐沙班的联合应用在预防髋关节或膝关节置换术后DVT的效果显著,能有效改善血流变学参数,抑制血液凝集,降低并发症发生率。

桃红四物汤联合针刺、洛芬待因缓释片治疗营血虚滞型神经根型颈椎病的效果分析

目的:分析桃红四物汤联合针刺、洛芬待因缓释片治疗营血虚滞型神经根型颈椎病的效果。方法:选取2021年10月—2022年10月北京市昌平区中西医结合医院收治的营血虚滞型神经根型颈椎病患者60例作为研究对象,随机分为观察组与对照组,各30例。对照组给予针刺联合洛芬待因缓释片治疗,观察组在对照组基础上给予桃红四物汤治疗。比较两组治疗效果。结果:观察组肢体麻木、颈椎疼痛、头晕头痛改善时间早于对照组,差异有统计学意义(P<0.05)。观察组复发率低于对照组,差异有统计学意义(P=0.044)。治疗后,两组疼痛评分低于治疗前,且观察组低于对照组,两组颈椎功能评分高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。观察组治疗总有效率高于对照组,差异有统计学意义(P=0.023)。治疗后,两组生理功能、社会功能、躯体疼痛、情感职能评分高于治疗前,且观察组高于对照组,差异有统计学意义(P<0.05)。结论:桃红四物汤联合针刺、洛芬待因缓释片治疗营血虚滞型神经根型颈椎病的效果显著,可快速改善患者临床症状,减轻疼痛,恢复颈椎功能,降低复发率,提高生活质量。

四物汤加减配合雷火灸治疗过敏性结膜炎临床观察

目的探讨四物汤加减配合雷火灸治疗过敏性结膜炎的临床效果。方法将110例过敏性结膜炎患者随机分为对照组(55例)和试验组(55例)。对照组给予盐酸奥洛他定滴眼液治疗,试验组在对照组基础上给予四物汤加减配合雷火灸治疗。两组患者均治疗4个疗程。比较两组临床疗效、眼部症状及角膜染色评分、血清体液免疫指标及泪液变态反应指标水平。结果治疗后试验组总有效率94.55%(52/55)高于对照组的78.18%(43/55)(P<0.05)。与对照组比较,试验组治疗后主要症状评分、次要症状评分及角膜染色评分均较低,血清免疫球蛋白E(IgE)、免疫球蛋白A(IgA)、免疫球蛋白G(IgG)水平较低,泪液组胺(HA)、嗜酸粒细胞阳离子蛋白(ECP)及白三烯B4(LTB4)水平较低(P<0.05)。结论四物汤加减配合雷火灸治疗过敏性结膜炎的临床效果确切,能显著缓解眼部症状及角膜染色,调节体液免疫功能,减轻眼部变态反应,值得临床推广应用。

垫枕结合加味桃红四物汤治疗单纯性胸腰椎压缩性骨折临床观察

目的探讨垫枕结合加味桃红四物汤治疗单纯性胸腰椎压缩性骨折的临床效果。方法选择2021年4月—2021年12月漳州正兴医院收治的单纯性胸腰椎压缩性骨折患者60例为研究对象,按抽签法分为对照组和观察组,每组30例。对照组给予加味桃红四物汤,观察组在对照组基础上采用垫枕干预,比较2组伤椎Cobb角、胸腰椎功能[Oswestry功能障碍指数(ODI)评分]、疼痛程度[视觉模拟量表(VAS)评分]、舒适状况及护理工作满意度。结果入院时2组Cobb角、ODI评分、VAS评分、舒适状况评分及护理工作满意度比较,差异无统计学意义(P>0.05);治疗1周后,观察组ODI及VAS评分均低于对照组,差异有统计学意义(P<0.05);观察组出院当天舒适状况及护理工作满意度评分均高于对照组,差异有统计学意义(P<0.05);治疗1个月后,观察组Cobb角小于对照组,差异有统计学意义(P<0.05)。结论单纯性胸腰椎压缩性骨折患者采用垫枕结合加味桃红四物汤治疗有利于改善患者胸腰椎功能,缓解疼痛程度,提高舒适状况及对骨科护理工作的满意度。

基于足三阴经筋理论的小针刀松解疗法联合桃红四物汤治疗早中期股骨头坏死研究

目的 研究在足三阴经筋理论指导下的闭合性小针刀松解疗法联合桃红四物汤治疗早中期股骨头坏死的临床效果。方法 选取2020年6月至2023年6月在该院就诊的72例早中期股骨头坏死患者作为研究对象,对其临床资料进行回顾性分析。根据治疗方案不同将患者分为2组,其中38例接受足三阴经筋理论指导下的闭合性小针刀松解疗法联合桃红四物汤治疗(观察组),另34例接受常规闭合性松解术治疗(对照组)。比较2组治疗效果,以及治疗前后髋关节功能、疼痛程度及生活质量评分。结果 观察组患者整体疗效优于对照组,差异有统计学意义(P<0.05)。治疗后3、6个月时,观察组患者Harris髋关节功能评分高于对照组,视觉模拟评分法评分低于对照组,差异均有统计学意义(P<0.05)。治疗后6个月时,观察组患者生理功能、躯体疼痛、活力、情感职能、社会功能、生理职能、精神健康及总体健康等简明健康状况调查问卷评分显著高于对照组,全血黏度高切、低切及血浆黏度水平均低于对照组,差异均有统计学意义(P<0.05)。结论 基于足三阴经筋理论指导下的小针刀松解术联合桃红四物汤治疗早中期股骨头坏死患者效果显著,有助于改善患者血液流变学,减轻躯体疼痛,提高患者生活质量。

基于网络药理学和分子对接预测桃红四物汤治疗黄褐斑的机制

目的基于网络药理学和分子对接技术探索桃红四物汤(THSWD)治疗黄褐斑所涉及的主要成分、相关靶点及作用通路。方法通过中医药系统药理学数据库与分析平台(TCMSP)、Swiss Target Prediction数据库、SymMap数据库、GeneCards数据库、STITCH数据库、比较毒理基因组学数据库(CTD)和疾病基因数据库Drugbank、GeneCards、OMIM、TTD、DisGeNET等分别搜索桃红四物汤的活性成分和黄褐斑的疾病基因靶点,将二者的靶点取交集,运用Cytoscape 3.9.1及STRING平台构建蛋白质互作(protein-protein interaction,PPI)网络。借助Metascape数据库对交集靶点进行基因本体论(gene ontology,GO)及京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)富集分析,最后由AutoDockTools 1.5.7实现活性成分和核心靶点的分子对接。结果挖掘桃红四物汤11139个潜在靶点,关键活性成分为叶酸、槲皮素、β-胡萝卜素、(+)-儿茶素、木脂素等。得到桃红四物汤治疗黄褐斑作用靶点53个,核心作用靶标有ALB、VEGFA、CD4、ESR1、CREB1。GO分析共获得509个生物过程条目、32个细胞组成条目和47个分子功能条目。KEGG分析共获得189条信号通路。分子对接结果显示,调控网络中的相关活性成分与核心靶基因具有较高的结合活性。结论基于网络药理学及分子对接预测桃红四物汤通过多种活性成分、多个靶点、多条通路的综合调控网络发挥治疗黄褐斑的作用。